Davis Scott G., CEO of Ekso Bionics Holdings ($EKSO), made one open market sale of common shares in the last year, totaling $111,912. His most recent transaction occurred on November 10, 2025. This ranks ninth thousand four hundred third out of 11,678 insiders by sales value, well below the average of $8.6 million across about 6.4 transactions. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 10, 2025 | EKSO BIONICS HOLDINGS, INC. | $EKSO | Davis Scott G. | CEO | S | Common Stock | 23315 | $4.80 | 79,150.0000 | 2,623,233 | 22.75% | 0.89% |
| Nov. 5, 2025 | EKSO BIONICS HOLDINGS, INC. | $EKSO | Davis Scott G. | CEO | A | Common Stock | 80000 | $0.00 | 102,465.0000 | 2,623,233 | 356.11% | 3.05% |
| March 14, 2025 | EKSO BIONICS HOLDINGS, INC. | $EKSO | Davis Scott G. | CEO | A | Common Stock | 5590 | $0.00 | 336,962.0000 | 24,824,762 | 1.69% | 0.02% |